טוען...
Labetalol infusion for refractory hypertension causing severe hypotension and bradycardia: an issue of patient safety
Incremental doses of intravenous labetalol are safe and effective and, at times, such therapy may need to be augmented by a continuous infusion of labetalol to control severe hypertension. Continuous infusions of labetalol may exceed the recommended maximum daily dose of 300 mg on occasion. We repor...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2008
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2429901/ https://ncbi.nlm.nih.gov/pubmed/18505576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1754-9493-2-13 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|